Dr. Steven A. Curley, Professor of Surgical Oncology, M. D., F.A.C.S. at MD Anderson Cancer Center is honored for his work at Kanzius Cancer Research Foundation. Dr. Curley led the development of a promising, non-invasive nano-particle radio-wave cancer treatment that fries hyper-targeted cancer cells.
Kanzius Cancer Research Foundation was a registered, 501(c)3 nonprofit organization from 2008-2014, made up of a group of dedicated individuals supporting the ongoing research of the Kanzius Noninvasive Radiowave Cancer Treatment project, an innovative treatment without any side effects. With a succinct mission to create national and global awareness of the potentials of this treatment and to raise funds to help accelerate the speed at which research progresses through human trials, the group worked to make “a better way” possible by funding all of the research necessary to present the technology to the FDA. They completed their mission. Remaining true to its mission and the cancer community they served, the Kanzius Foundation granted all of its remaining assets and donations to three, newly created funds to facilitate Phase II human clinical trials in the hometown communities of John Kanzius (Erie, PA and Sanibel, FL) and in several additional, to-be-determined locations. Each fund bears the name of John Kanzius and will provide resources for each institution to administer the program once trials begin.